SEARCH

SEARCH BY CITATION

References

  • American Association of Blood Banks (2002) In: Blood Transfusion Therapy: A Physician's Handbook, 7th edn (ed. by D.J.Triulzi). American Association of Blood Banks, Bethesda, MD.
  • Atance, R., Pereira, A. & Ramirez, B. (2001) Transfusing methylene blue – photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion, 41, 15481552.
  • Baglin, T. (1998) Management of warfarin (coumarin) overdose. Blood Review, 12, 9198.
  • BCSH (1988) Guidelines for transfusion for massive blood loss. Clinical Laboratory Haematology, 10, 265273.
  • BCSH (1990a) Guidelines on hospital blood bank documentations and procedures. Journal of Clinical Laboratory and Haematology, 12, 209220.
  • BCSH (1990b) Guidelines on oral anticoagulation: second edition. Journal of Clinical Pathology, 43, 177183.
  • BCSH (1992) Guidelines for the use of fresh frozen plasma. Transfusion Medicine, 2, 5763.
  • BCSH (1994) Guidelines for administration of blood products, transfusion of infants and neonates. Transfusion Medicine, 4, 6369.
  • BCSH (1998) Guidelines on oral anticoagulation: third edition. British Journal of Haematology, 101, 374385.
  • BCSH (1999) Guidelines for administration of blood products, and management of transfused patients. Transfusion Medicine, 9, 227238.
  • BCSH (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. British Journal of Haematology, 120, 556573.
  • BCSH (2004) Guidelines on the transfusion of neonates and older children. British Journal of Haematology, 124, 433453.
  • Bjerrum, O.S. & Jersild, C. (1971) Class specific anti-IgA associated with severe anaphylactic transfusion reactions in a patient with pernicious anaemia. Vox Sanguinis, 21, 411424.
  • Bull, B.S., Huse, W.M., Brauer, F.S. & Korpman, R.A. (1975) Heparin therapy during extracorporeal circulation: II. The use of a dose-response curve to individualize heparin and protamine dosage. Journal of Thoracic and Cardiovascular Surgery, 69, 686689.
  • Carson, J.L., Poses, R.M., Spence, R.K. & Bonavita, G. (1988) Severity of anaemia and operative mortality and morbidity. Lancet, 331, 727729.
  • Ciavarella, D., Reed, R.L., Counts, R.B., Pavlin, E., Baron, L., Heimbach, D.M. & Carrico, J. (1987) Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. British Journal of Haematology, 67, 365368.
  • Cohen, H. (1993) Avoiding the use of FFP. British Medical Journal, 307, 395396.
  • College of American Pathologists Practice Guidelines Development Task Force (1994) Practice parameters for the usage of FFP, cryo and platelets. Journal of the American Medical Association, 271, 777781.
  • Council of Europe (2004) Guide to the Preparation, Use and Quality Assurance of Blood Components, 10th edn. Council of Europe Publishing, Strasbourg.
  • De la Rubia, J., Arriaga, F., Linares, D., Larrea, L., Carpio, N., Marty, M.L. & Sanz, M.A. (2001) Role of methylene blue treated of fresh frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopic purpura. British Journal of Haematology, 114, 721723.
  • Department of Health (1998) Vitamin K for New Born Babies. PL/CMO/98/3, PL/CMO/98/4. Department of Health, London.
  • Det Norske Veritas (1999) Assessment of the Risk of Exposure to vCJD Infectivity in Blood and Blood Products. A Report to Spongiform Encephalopathy Advisory Committee. Det Norske Veritas, London.
  • Dyer, C. (2003) Second vCJD patient to receive experimental treatment. British Medical Journal, 273, 886.
  • Eagleton, H., Benjamin, S. & Murphy, M.F. (2000) Audits of appropriate use of FFP. Bloods Matters, 4, 58.
  • Eder, A.F. & Manno, C.S. (2001) Does red cell T activation matter? British Journal of Haematology, 114, 2530.
  • Evans, G., Llewelyn, C., Luddington, R., Baglin, T.P. & Williamson, L.M. (1999) Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura. Clinical and Laboratory Haematology, 21, 119123.
  • Food Standards Agency (2003) OTM Rule Review: Core Stakeholder Group Report. WWW document. URL: http://www.foodstandards.gov.uk.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lammle, B. (1998) Von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome. New England Journal of Medicine, 339, 1578.
  • Garwood, M., Cardigan, R.A., Drummond, O., Hornsey, V., Turner, C.P., Young, D., Williamson, L.M. & Prowse, C.V. (2003) The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma. Transfusion, 43, 12381247.
  • Goodnough, L.T. (1999) Transfusion Medicine 2nd of 2 parts. New England Journal of Medicine, 340, 525533.
  • Green, G., Dymock, I.W., Poller, L. & Thomson, J.M. (1975) Use of factor VII-rich prothromin complex concentrate in liver disease. Lancet, 1, 13111314.
  • Harke, H. & Rahman, S. (1980) Haemostatic disorders in massive transfusion. Biblioteca Haematologica, 46, 179188.
  • Harrison, C.N. Lawrie, A.S., Iqbal, A., Hunter, A. & Machin, S.J. (1996) Plasma exchange with solvent/detergent plasma of resistant thrombotic thrombocytopenic purpura. British Journal of Haematology, 94, 756758.
  • Hellstern, P. & Haubelt, H. (2002) Indications for plasma in massive transfusion. Thrombosis Research, 107(Suppl. 1), S19S22.
  • Hett, D.A., Walker, D., Pilkington, S.N. & Smith, D.C. (1995) Sonoclot analysis. British Journal of Anaesthesia, 75, 771776.
  • Hewitt, P.E. & Machin, S.J. (1990) Massive blood transfusion. British Medical Journal, 300, 107109.
  • Hiippala, S.T., Myllyla, G. & Vahtera, E.M. (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia, 81, 360365.
  • Hilton, D.A., Ghani, A.C., Conyers, L., Edwards, P., McCardle, L., Penney, M., Ritchie, D. & Ironside, J.W. (2002) Accumulation of prion protein in tonsil and appendix: review of tissue samples. British Medical Journal, 325, 633634.
  • Horrow, J.C., Hlavecek, J., Strong, M.D., Collier, W., Brodsky, I., Goldman, S.M. & Goel, I.P. (1990) Prophylactic tranexamic acid decreases bleeding after cardiac operations. Journal of Thoracic and Cardiovascular Surgery, 99, 7074.
  • Houston, F., Foster, J.D., Chong, A., Hunter, N. & Bostock, C.J. (2000) Transmission of BSE by blood transfusion in sheep. Lancet, 356, 9991000.
  • Hunt, B.J. (1991) Modifying periperative blood loss. Blood Reviews, 5, 168176.
  • Hunter, N., Foster, J., Chong, A., McCutcheon, S., Parnham, D., Eaton, S., MacKenzie, C. & Houston, F. (2002) Transmission of prion diseases by blood transfusion. Journal of General Virology, 83, 28972905.
  • Jain, N., Kirschbaum, N., Gaines, A., Coignard, B., Jarvis, W. & Silverman, T. (2003) Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma. Journal of Thrombosis and Haemostasis, 1(Suppl. 1), abstract no. OC159.
  • Kopto, P.M. & Holland, P.V. (1999) Transfusion related acute lung injury. British Journal of Haematology, 105, 322329.
  • Lakkis, N.M., George, S., Thomas, E., Ali, M., Guyer, K. & Carville, D. (2001) Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors. Catheterization and Cardiovascular Interventions, 53, 346351.
  • Laupacis, A. & Fergusson, D. for the International Study of Peri-Operative Transfusion (ISPOT) Investigators (1997) Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anaesthesth and Analgesia, 85, 12581267.
  • Levi, M. & ten Cate, H. (1999) Disseminated intravascular coagulation. New England Journal of Medicine, 341, 586592.
  • MacGregor, I., Hope, J., Barnard, G., Kirby, L., Drummond, O., Pepper, D., Hornsey, V., Barclay, R., Bessos, H., Turner, M. & Prowse, C. (1999) Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sanguinis, 77, 8896.
  • Machin, S.J. (1984) Thrombotic thrombocytopenia purpura. British Journal of Haematology, 56, 191197.
  • Makris, M. & Watson, H.G. (2001) The management of coumarin induced over anticoagulation. British Journal of Haematology, 114, 271280.
  • Makris, M., Greaves, M., Phillips, W.S., Kitchen, S., Rosendaal, F.R. & Preston, F.E. (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and Haemostasis, 77, 477480.
  • Male, C., Johnston, M., Sparling, C., Brooker, L., Andrew, M. & Massicotte, P. (1999) The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood. Clinics in Laboratory Medicine, 19, 3969.
  • Mannucci, P.M., Franchi, F. & Diaguardi, N. (1976) Correction of abnormal coagulation in chronic liver disease by combined use of fresh frozen plasma and prothrombin complex concentrates. Lancet, 2, 542545.
  • Mannucci, P.M., Federici, A.B. & Sirchia, G. (1982) Haemostasis testing during massive blood replacement. A study of 127 cases. Vox Sanguinis, 42, 113123.
  • Mansouri, A. & Lurie, A.A. (1993) Consise review: methaemoglobinaemia. American Journal of Haematology, 42, 712.
  • McClelland, D.B.L. (ed.) (2001) The Handbook of Transfusion Medicine, 3rd edn. HMSO, London. http://www.thestationeryoffice.co.uk/nbs/handbook2001/index.htm.
  • Mollison, P.L. (1972) Blood Transfusion in Clinical Medicine, 5th edn. Blackwell Scientific Publications, Oxford, p. 188.
  • Murphy, M.F. (1999) NV CJD, the risk of transmission by blood transfusion and potential benefit of leucocyte reduction of blood components. Transfusion Medicine Reviews, 13, 7583.
  • Murphy, M.E. (2001) Febrile reactions and TRALI. In: Practical Transfusion Medicine (ed. by Murphy, M.F. & Pamphilon, D.H.), pp. 157163. Blackwell Science, Oxford.
  • Northern Neonatal Nursing Initiative Trial Group (1996) Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years. Lancet, 348, 229232.
  • O'Shaughnessy, D.F. (2000) Communication theory in the setting of blood transfusion in a DGH, MBA thesis. Oxford Brookes University.
  • Osborn, D.A., Lui, K., Pussell, P., Jana, A.K., Desai, A.S. & Cole, M. (1999) T and Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness and effectiveness of testing. Archives of Diseases in Childhood, Fetal and Neonatal Edition, 80, 192F197F.
  • Palfi, M., Berg, S., Ernerudh, J. & Berlin, G. (2001) A randomized controlled trial of transfusion related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion, 41, 317322.
  • Pamphilon, D.H. (2000) Viral inactivation of FFP. British Journal of Haematology, 109, 680693.
  • Peters, D.C. & Noble, S. (1998) Aprotinin: an update of its pharmacology of therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs, 57, 233260.
  • Pincock, S. (2004) Patient's death from vCJD may be linked to blood transfusion. Lancet, 363, 43.
  • Popovsky, M.A., Chaplin, Jr, H.C. & Moore, S.B. (1992) Transfusion related acute lung injury a neglected, serious complication of haemotherapy. Transfusion, 32, 589592.
  • Rock, G., Shumak, K.H., Sutton, D.M.C., Buskard, N.A., Nair, R.C., Michelson, A.D. & Members of the Canadian Apheresis Group (1996) Cryosupernatant as repalcement fluid for plasma exchange in the thrombotic thrombocytopenic purpura. British Journal of Haematology, 39, 12271234.
  • Sandler, G.S., Mallory, D., Malamui, D. & Eckrich, R. (1995) IgA anaphylactic transfusion reactions. Transfusion Medicine Reviews, 9, 18.
  • Sazama, K. (1994) Bacteria in blood for transfusion: a review. Archives of Pathology Laboratory Medicine, 118, 350365.
  • Serious Hazards of Transfusion (2001) Annual Report 1999–2000. ISBN 0 9532 789 3 X.
  • Serious Hazards of Transfusion (2002) Annual Report 2000–2001. ISBN 0 9532 789 4 8.
  • Serious Hazards of Transfusion (2003) Annual Report 2001–2002. ISBN 0 9532 789 5 6.
  • Shehata, N., Blajchman, M. & Heddle, N. (2001) Coagulation factors in FFP and cryosupernatant. Transfusion Medicine, 11, 391401.
  • Shore-Lesserson, L., Manspeizer, H.E., DePerio, M., Francis, S., Vela-Cantos, F. & Ergin, M.A. (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anaesthesia and Analgesia, 88, 312319.
  • Silliman, C.C., Boshkov, L.K., Mehdizadehkashi, Z. Elzi, D.J., Dickey, W.O., Podlosky, L. Clarke, G. & Ambruso, D.R. (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood, 101, 454462.
  • Solheim, B.G. & Hellstern, P. (2003) Composition, efficacy, and safety of S/D-treated plasma (letter). Transfusion, 43, 11761178.
  • Solheim, B.G., Rollag, H., Svennevig, J., Arafa, O., Fosse, E. & Bergerud, U. (2000) Viral Safety of solvent/detergent treated plasma. Transfusion, 40, 8490.
  • Stainsby, D. & Burrowes-King, V. (2001) A National Audit of the Use of Fresh Frozen Plasma. NBS. WWW docment. URL: http://www.nbsweb/med/ca/pf/ffprep.pdf
  • Stainsby, D., MacLennan, S. & Hamilton, P.J. (2000) Commentary. Management of massive blood loss: a template guideline. British Journal of Anaesthesia, 85, 487491.
  • Stanworth, S.J., Brunskill, S.J., Hyde, C.J., McClelland, D.B.L. & Murphy, M.F. (2004) Is FFP clinically effective? A systematic review of randomised controlled trials. British Journal of Haematology, in press.
  • Turner, M.L. & Ironside, J.W. (1998) New variant CJD: the risk of transmission via blood products. Blood Reviews, 12, 255268.
  • United Kingdom Blood Transfusion Services/National Institute for Biological Standards and Control (2002) Guidelines for the Blood Transfusion Services in the United Kingdom, 6th edn. TSO. WWW document. URL: http://www.thestationeryoffice.com.nbs/rdbk2001/guidelines.htm and http://www.transfusionguidelines.org.uk.
  • United Kingdom Haemophilia Centre Directors’ Organisation (1997) Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders. Haemophilia, 3, 6377.
  • United Kingdom Haemophilia Centre Directors’ Organisation (2003) Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia, 9, 123.
  • Will, R.G., Ironside, J.W., Zeider, M., Cousens, S.N., Estiberio, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A. & Smith, P.G. (1996) A new variant of Creutzfeldt–Jakob disease in the UK. Lancet, 347, 921925.
  • Williamson, L.M. (2001) Storage of blood components. In: Practical Transfusion Medicine (ed. by M.F.Murphy & D.H.Pamphilon), pp. 231243. Blackwell Science, Oxford.
  • Williamson, L.M., Llewelyn, C.A., Fisher, N.F., Allain, J.-P., Bellamy, M.C., Baglin, T.P., Freeman, J., Klinck, J.K., Ala, F.A., Smith, N., Neuberger, J. & Wreghitt, T.G. (1999) A randomised trial of solvent/detergent and standard fresh frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion, 39, 12271234.
  • Wuillemin, W.A., Gasser, K.M., Zeerleder, S.S. & Lammle, B. (2002) Evaluation of a platelet function analyser (PFA 100) in patients with a bleeding tendency. Swiss Medical Weekly, 132, 443448.
  • Yarranton, H., Cohen, H., Pavord, S.R., Benjamin, S., Hagger, D. & Machin, S.J. (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. British Journal of Haematology, 121, 778785.
  • Zeigler, Z.R., Shadduck, R.K., Gryn, J.F., Rintels, P.B., George, J.N., Besa, E.C., Bodensteiner, D., Silver, B., Kramer, B.E. & The North American TTP Group (2001) Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura. Journal of Clinical Apheresis, 16, 1922.
  • Zipursky, A. (1998) Prevention of vitamin K deficiency. Bleeding in newborns. British Journal of Haematology, 104, 430437.